Supplementary Figure Legend from MAPK Kinase 3 Is a Tumor Suppressor with Reduced Copy Number in Breast Cancer

Adam J. MacNeil,Shun-Chang Jiao,Lori A. McEachern,Yong Jun Yang,Amanda Dennis,Haiming Yu,Zhaolin Xu,Jean S. Marshall,Tong-Jun Lin

DOI: https://doi.org/10.1158/0008-5472.22399536

2023-01-01

Abstract:PDF file - 86K

What problem does this paper attempt to address?

Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Jiahui Mou,Meijun Huang,Feifei Wang,Xiaoding Xu,Hanqi Xie,Henglei Lu,Mingyang Li,Yu Li,Weiwen Kong,Jing Chen,Ying Xiao,Yiding Chen,Chaochen Wang,Jin Ren

DOI: https://doi.org/10.1158/1541-7786.22527890

2023-01-01

Abstract:Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis
Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced let-7g Expression in Breast Cancer Invasion and Metastasis

Pengxu Qian,Zehua Zuo,Zhengsheng Wu,Xianyi Meng,Gaopeng Li,Zhengzhou Wu,Weijie Zhang,Sheng Tan,Vijay Pandey,Yandan Yao,Puyue Wang,Liqing Zhao,Jun Wang,Qiang Wu,Erwei Song,Peter E. Lobie,Zhinan Yin,Tao Zhu

DOI: https://doi.org/10.1158/0008-5472.22391054

2023-01-01

Abstract:PDF file - 214K
Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Junying Zeng,Sharad Sharma,Yong‐Qing Zhou,Hang‐Ping Yao,Xing Hu,Ruiwen Zhang,Ming-Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22503690

2023-01-01

Abstract:PDF - 71K, Legends for Supplementary Figures 1 through 5.
Supplementary Figure Legends from miR-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3

Ying Zhou,Jason Dang,Kung-Yen Chang,Edwin Yau,Pedro Aza-Blanc,Jorge Moscat,Tariq M. Rana

DOI: https://doi.org/10.1158/0008-5472.22409370.v1

2023-01-01

Abstract:Legend for Supplementary Figures S1-S8
Figure Legends for Supplementary Figures from Analysis of Mtor Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K–AKT–mTOR Pathway Inhibitors

Yan Kong,Lu Si,Yiqian Li,Xiaowen Wu,Xiaowei Xu,Jie Dai,Huan Tang,Meng Ma,Zhihong Chi,Xinan Sheng,Chuanliang Cui,Jun Guo

DOI: https://doi.org/10.1158/1078-0432.22461800.v1

2023-01-01

Abstract:Figure legends for Supplementary Figure S1 and Figure S2
Supplementary Methods and Materials, Figure Legend from ZBTB7A Suppresses Melanoma Metastasis by Transcriptionally Repressing MCAM

Xuesong Liu,Matthew Genet,Jenna E. Haines,Elie K. Mehanna,Shanshan Wu,Hung-I Harry Chen,Yidong Chen,Abrar A. Qureshi,Jiali Han,Xiang Chen,David E. Fisher,Pier Paolo Pandolfi,Yuan Zhang

DOI: https://doi.org/10.1158/1541-7786.22514197

2023-01-01

Abstract:Supplementary Methods and Materials, Figure Legend
Supplementary Figure Legends from Ablation of Mir-10B Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways

Jongchan Kim,Ashley N. Siverly,Dahu Chen,Min Wang,Yuan,Yumeng Wang,Hyemin Lee,Jinsong Zhang,William J. Muller,Han Liu,Boyi Gan,Xianbin Yang,Yeneng Sun,M. James You,Ma Li

DOI: https://doi.org/10.1158/0008-5472.22413063.v1

2023-01-01

Abstract:Legends for Supplementary Figures S1-S11
Supplementary Figure Legends from Upregulation of Cytosolic Phosphoenolpyruvate Carboxykinase Is a Critical Metabolic Event in Melanoma Cells That Repopulate Tumors

Yong Li,Shunqun Luo,Ruihua Ma,Jing Liu,Pingwei Xu,Huafeng Zhang,Ke Tang,Jingwei Ma,Yi Zhang,Xiaoyu Liang,Yanling Sun,Tiantian Ji,Ning Wang,Bo Huang

DOI: https://doi.org/10.1158/0008-5472.22410020

2023-01-01

Abstract:Legends for Supplementary Figures S1-S8.
Supplementary Figure Legends from Accelerated Tumor Growth Mediated by Sublytic Levels of Antibody-Induced Complement Activation is Associated with Activation of the PI3K/AKT Survival Pathway

Xiaohong Wu,Govind Ragupathi,Katherine S. Panageas,Feng Hong,Philip O. Livingston

DOI: https://doi.org/10.1158/1078-0432.22446662

2023-01-01

Abstract:Legend for supplementary figures - PDF file 62K, Supplementary Figure Legend
Supplementary Figure Legends from RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer

Yajing Liu,Monika L. Burness,Rachel Martin-Trevino,Joey Guy,Shoumei Bai,Ramdane Harouaka,Michael Brooks,Shang Li,Alex Fox,Tahra Luther,April Davis,Trenton L. Baker,Justin A. Colacino,Shawn G. Clouthier,Zhi‐Ming Shao,Max S. Wicha,Suling Liu

DOI: https://doi.org/10.1158/1078-0432.22460774.v1

2023-01-01

Abstract:Supplementary figures 1-8 legends
Supplementary Figure 2 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401687

2023-01-01

Abstract:PDF file - 131K, LCN2 does not affect ERK and NF-kB pathways.
Supplementary Figure and Table Legends from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells

Li Lin,Brian Hutzen,Mingxin Zuo,Sarah Ball,Stephanie Deangelis,Elizabeth Foust,Bulbul Pandit,Michael A. Ihnat,Satyendra S. Shenoy,Samuel Kulp,Pui-Kai Li,Chenglong Li,James Fuchs,Jiayuh Lin

DOI: https://doi.org/10.1158/0008-5472.22387137.v1

2023-01-01

Abstract:Supplementary Figure and Table Legends from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells
Supplementary Figures 1-7 from Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells

David J. Mulholland,Naoko Kobayashi,Marcus Ruscetti,Allen Zhi,Linh M. Tran,Jiaoti Huang,Martin Gleave,Hong Wu

DOI: https://doi.org/10.1158/0008-5472.22391619

2023-01-01

Abstract:PDF file - 1.5MB
Supplementary Methods and Figure Legends from Distinct FAK Activities Determine Progenitor and Mammary Stem Cell Characteristics

Ming Luo,Xiaofeng Zhao,Song Chen,Suling Liu,Max S. Wicha,Jun-Lin Guan

DOI: https://doi.org/10.1158/0008-5472.22398173

2023-01-01

Abstract:PDF file, 624K, PyMT-induced tumor cells have a luminal cellular origin and FAK inhibitor treatment does not induce significant apoptosis in SUM149 and SUM159 breast cancer cells.
Supplementary Figure Legends 1-4 from the Tumor Suppressor LKB1 Regulates Lung Cancer Cell Polarity by Mediating Cdc42 Recruitment and Activity

Shumin Zhang,Katherine Schafer-Hales,Fadlo R. Khuri,Wei Zhou,Paula M. Vertino,Adam I. Marcus

DOI: https://doi.org/10.1158/0008-5472.22374815

2023-01-01

Abstract:Supplementary Figure Legends 1-4 from The Tumor Suppressor LKB1 Regulates Lung Cancer Cell Polarity by Mediating cdc42 Recruitment and Activity
Supplementary Figure and Table Legends from A Diverse Array of Cancer-Associated mtor Mutations Are Hyperactivating and Can Predict Rapamycin Sensitivity

Brian C. Grabiner,Valentina Nardi,Kıvanç Birsoy,Richard Possemato,Kuang Shen,Sumi Sinha,Alexander Jordan,Andrew H. Beck,David M. Sabatini

DOI: https://doi.org/10.1158/2159-8290.22529639

2023-01-01

Abstract:PDF file 82K, Supplementary Figure and Table Legends
Supplementary Figure Legends from Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non–Small Cell Lung Cancer

Yifan Wang,Nan Li,Jinyu Wen,Weiye Deng,Rui Ye,Xu Cai,Yawei Qiao,Amrish Sharma,Ming Zhang,Mien‐Chie Hung,Steven H. Lin

DOI: https://doi.org/10.1158/1078-0432.22469730.v1

2023-01-01

Abstract:Supplementary figure legends
Supplementary Figure 7 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Guangcun Cheng,Xueqing Sun,Jinglong Wang,Gang Xiao,Xiumin Wang,Xuemei Fan,Lidong Zu,Mingang Hao,Qing Qu,Yan Mao,Yunjing Xue,Jianhua Wang

DOI: https://doi.org/10.1158/0008-5472.22401672

2023-01-01

Abstract:PDF file - 132K, LCN2 does not affect PTEN activity.
Supporting Figure Legends from Targeting BRK-Positive Breast Cancers with Small-Molecule Kinase Inhibitors

Jie Jiang,Fu Gui,Zhiguo He,Li,Yunzhan Li,Shunying Li,Xinrui Wu,Zhiyong Deng,Xihuan Sun,Xin Huang,Wei Huang,Shang Han,Ting Zhang,Zheng Wang,Bo Jiang,Siyang Song,Hongrui Wang,Lanfen Chen,Dawang Zhou,Qiang Liu,Ruibao Ren,Jianming Zhang,Xin Deng

DOI: https://doi.org/10.1158/0008-5472.22413276.v1

2023-01-01

Abstract:Supplementary figure legends
Supplementary Figure 1 from Binding of the JmjC Demethylase JARID1B to LSD1/NuRD Suppresses Angiogenesis and Metastasis in Breast Cancer Cells by Repressing Chemokine CCL14

Qian Li,Lei Shi,Bin Gui,Wenhua Yu,Jiamu Wang,Di Zhang,Xiao Han,Zhi Yao,Yongfeng Shang

DOI: https://doi.org/10.1158/0008-5472.22388579

2023-01-01

Abstract:PDF file - 57K

Supplementary Figure Legend from MAPK Kinase 3 Is a Tumor Suppressor with Reduced Copy Number in Breast Cancer

Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced <i>let-7g</i> Expression in Breast Cancer Invasion and Metastasis

Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Supplementary Figure Legends from miR-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3

Figure Legends for Supplementary Figures from Analysis of Mtor Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K–AKT–mTOR Pathway Inhibitors

Supplementary Methods and Materials, Figure Legend from ZBTB7A Suppresses Melanoma Metastasis by Transcriptionally Repressing MCAM

Supplementary Figure Legends from Ablation of Mir-10B Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways

Supplementary Figure Legends from Upregulation of Cytosolic Phosphoenolpyruvate Carboxykinase Is a Critical Metabolic Event in Melanoma Cells That Repopulate Tumors

Supplementary Figure Legends from Accelerated Tumor Growth Mediated by Sublytic Levels of Antibody-Induced Complement Activation is Associated with Activation of the PI3K/AKT Survival Pathway

Supplementary Figure Legends from RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer

Supplementary Figure 2 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure and Table Legends from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells

Supplementary Figures 1-7 from <i>Pten</i> Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells

Supplementary Methods and Figure Legends from Distinct FAK Activities Determine Progenitor and Mammary Stem Cell Characteristics

Supplementary Figure Legends 1-4 from the Tumor Suppressor LKB1 Regulates Lung Cancer Cell Polarity by Mediating Cdc42 Recruitment and Activity

Supplementary Figure and Table Legends from A Diverse Array of Cancer-Associated <i>mtor</i> Mutations Are Hyperactivating and Can Predict Rapamycin Sensitivity

Supplementary Figure Legends from Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non–Small Cell Lung Cancer

Supplementary Figure 7 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supporting Figure Legends from Targeting BRK-Positive Breast Cancers with Small-Molecule Kinase Inhibitors

Supplementary Figure 1 from Binding of the JmjC Demethylase JARID1B to LSD1/NuRD Suppresses Angiogenesis and Metastasis in Breast Cancer Cells by Repressing Chemokine CCL14

Supplementary Figure Legend from MAPK Kinase 3 Is a Tumor Suppressor with Reduced Copy Number in Breast Cancer

Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced &lt;i&gt;let-7g&lt;/i&gt; Expression in Breast Cancer Invasion and Metastasis

Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Supplementary Figure Legends from miR-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3

Figure Legends for Supplementary Figures from Analysis of Mtor Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K–AKT–mTOR Pathway Inhibitors

Supplementary Methods and Materials, Figure Legend from ZBTB7A Suppresses Melanoma Metastasis by Transcriptionally Repressing MCAM

Supplementary Figure Legends from Ablation of Mir-10B Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways

Supplementary Figure Legends from Upregulation of Cytosolic Phosphoenolpyruvate Carboxykinase Is a Critical Metabolic Event in Melanoma Cells That Repopulate Tumors

Supplementary Figure Legends from Accelerated Tumor Growth Mediated by Sublytic Levels of Antibody-Induced Complement Activation is Associated with Activation of the PI3K/AKT Survival Pathway

Supplementary Figure Legends from RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer

Supplementary Figure 2 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supplementary Figure and Table Legends from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells

Supplementary Figures 1-7 from &lt;i&gt;Pten&lt;/i&gt; Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells

Supplementary Methods and Figure Legends from Distinct FAK Activities Determine Progenitor and Mammary Stem Cell Characteristics

Supplementary Figure Legends 1-4 from the Tumor Suppressor LKB1 Regulates Lung Cancer Cell Polarity by Mediating Cdc42 Recruitment and Activity

Supplementary Figure and Table Legends from A Diverse Array of Cancer-Associated &lt;i&gt;mtor&lt;/i&gt; Mutations Are Hyperactivating and Can Predict Rapamycin Sensitivity

Supplementary Figure Legends from Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non–Small Cell Lung Cancer

Supplementary Figure 7 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression Through Misregulation of LCN2

Supporting Figure Legends from Targeting BRK-Positive Breast Cancers with Small-Molecule Kinase Inhibitors

Supplementary Figure 1 from Binding of the JmjC Demethylase JARID1B to LSD1/NuRD Suppresses Angiogenesis and Metastasis in Breast Cancer Cells by Repressing Chemokine CCL14

Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced <i>let-7g</i> Expression in Breast Cancer Invasion and Metastasis

Supplementary Figures 1-7 from <i>Pten</i> Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells

Supplementary Figure and Table Legends from A Diverse Array of Cancer-Associated <i>mtor</i> Mutations Are Hyperactivating and Can Predict Rapamycin Sensitivity